Diasome is developing hepatocyte directed vesicle (HDV) nanotechnology to lessen the instances of high and low blood sugar levels in people with diabetes to improve disease management and quality of life. HDV nanotechnology can be added to any available insulin to improve its safety and efficacy by restoring the liver’s natural role in blood glucose control.


Get In Touch With Us